Condoliase (Seikagaku corporation)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCondoliase (Seikagaku corporation)
Drug Alias NameC-ABCChABCHernicoreSI-6603
ClassificationBiologics > Protein drugs > Enzyme > Non-recombinant enzyme
Mechanisms of ActionGlycosaminoglycan modulatorsChondroitin sulfate proteoglycans modulators
TargetsChondroitin sulfate proteoglycansGlycosaminoglycan
Therapy Area/IndicationsIntervertebral disc diseaseHerniaIntervertebral Disc Displacement
Global Approved IndicationsIntervertebral Disc Displacement
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2018/03/01
Country/TerritoryUnited StatesRomaniaGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSeikagaku
China Registration ClassN/A

Develop Information

Active CompaniesSeikagaku CoSeikagakuFerring Bv +[4] 
Inactive CompaniesN/A
Active IndicationsIntervertebral Disc Displacement
Inactive IndicationsIntervertebral disc diseaseHernia

Other Information

ATC CodeM05
Related LinksN/A